Showing results (31-40 of 646) with videos related to
Sort By:
Pageof 65
Seminars in Oncology|January 8, 2017
Combination therapy for fit (younger and older) newly diagnosed multiple myeloma patients: Data support carfilzomib, lenalidomide, and dexamethasone independent of cytogenetic risk statusOla LandgrenHematology. American Society of Hematology. Education Program|December 10, 2021
Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic eventsOla LandgrenEuropean Journal of Haematology|February 20, 2014
Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study GroupLev Shvidel, Tamar Tadmor, Andrei Braester, et al.Annals of Hematology|January 1, 2013
Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 casesLev Shvidel, Tamar Tadmor, Andrei Braester, et al.European Journal of Haematology|October 5, 2012
Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study GroupOsnat Bairey, Neta Goldschmidt, Rosa Ruchlemer, et al.Leukemia Research|February 12, 2013
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomasAlessia Bari, Tamar Tadmor, Stefano Sacchi, et al.Annals of Hematology|May 25, 2012
Cell surface expression of CD25 antigen (surface IL-2 receptor α-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patientsLev Shvidel, Andrei Braester, Osnat Bairey, et al.Cancers|October 23, 2021
Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel AgentsTamar Tadmor, Ilana LevyLeukemia & Lymphoma|October 15, 2008
Epidemiology, pathology and treatment of non-follicular indolent lymphomasOla Landgren, Hervé TillyPageof 65